Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Langdon

Showing results (41-50 of 180) with videos related to

Pageof 18
Sort By:
General Pharmacology|February 1, 1997
Preclinical studies on the broad-spectrum neuropeptide growth factor antagonist GD A Jones, J Cummings, S P Langdon, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1984
The chemosensitivity of a new experimental model--the M5076 reticulum cell sarcomaS P Langdon, A Gescher, J A Hickman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
The antitumour effect and toxicity of cis-platinum and N-methylformamide in combinationE S Harpur, S P Langdon, S A Fathalla, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
Paracrine regulation of ovarian cancer by endothelinS Moraitis, W R Miller, J F Smyth, et al.
Breast Cancer Research : BCR|December 24, 2025
The significance of molecular heterogeneity in breast cancer batch correction and dataset integrationNicholas Moir, Dominic A Pearce, Simon P Langdon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Mitogenic effects of epidermal growth factor and transforming growth factor-alpha on EGF-receptor positive human ovarian carcinoma cell linesA J Crew, S P Langdon, E P Miller, et al.
The British Journal of Cancer. Supplement|June 1, 1991
Modulation of the cluster 1 and mucin antigens in human small cell lung cancer and other epithelial tumour cell lines after treatment with the differentiation inducing agent, sodium butyrateF G Hay, L W Duncan, S P Langdon, et al.
Journal of Chromatography. B, Biomedical Applications|March 4, 1994
Determination of two neuropeptide growth factor antagonists, [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-substance P and [Arg6,D-Trp7,9,N-MePhe8]- substance P(6-11), by high-performance liquid chromatography with electrochemical detectionJ Cummings, A MacLellan, S P Langdon, et al.
Differentiation; Research in Biological Diversity|August 1, 1992
The influence of type I collagen on the growth and differentiation of the human colonic adenocarcinoma cell line HT-29 in vitroJ A East, S P Langdon, K M Townsend, et al.
Frontiers in Oncology|February 20, 2014
Customizing the therapeutic response of signaling networks to promote antitumor responses by drug combinationsAlexey Goltsov, Simon P Langdon, Gregory Goltsov, et al.
Pageof 18

Showing results (41-50 of 180) with videos related to

Sort By:
Pageof 18
General Pharmacology|February 1, 1997
Preclinical studies on the broad-spectrum neuropeptide growth factor antagonist GD A Jones, J Cummings, S P Langdon, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1984
The chemosensitivity of a new experimental model--the M5076 reticulum cell sarcomaS P Langdon, A Gescher, J A Hickman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
The antitumour effect and toxicity of cis-platinum and N-methylformamide in combinationE S Harpur, S P Langdon, S A Fathalla, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
Paracrine regulation of ovarian cancer by endothelinS Moraitis, W R Miller, J F Smyth, et al.
Breast Cancer Research : BCR|December 24, 2025
The significance of molecular heterogeneity in breast cancer batch correction and dataset integrationNicholas Moir, Dominic A Pearce, Simon P Langdon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Mitogenic effects of epidermal growth factor and transforming growth factor-alpha on EGF-receptor positive human ovarian carcinoma cell linesA J Crew, S P Langdon, E P Miller, et al.
The British Journal of Cancer. Supplement|June 1, 1991
Modulation of the cluster 1 and mucin antigens in human small cell lung cancer and other epithelial tumour cell lines after treatment with the differentiation inducing agent, sodium butyrateF G Hay, L W Duncan, S P Langdon, et al.
Journal of Chromatography. B, Biomedical Applications|March 4, 1994
Determination of two neuropeptide growth factor antagonists, [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-substance P and [Arg6,D-Trp7,9,N-MePhe8]- substance P(6-11), by high-performance liquid chromatography with electrochemical detectionJ Cummings, A MacLellan, S P Langdon, et al.
Differentiation; Research in Biological Diversity|August 1, 1992
The influence of type I collagen on the growth and differentiation of the human colonic adenocarcinoma cell line HT-29 in vitroJ A East, S P Langdon, K M Townsend, et al.
Frontiers in Oncology|February 20, 2014
Customizing the therapeutic response of signaling networks to promote antitumor responses by drug combinationsAlexey Goltsov, Simon P Langdon, Gregory Goltsov, et al.
Pageof 18